PharmD Info

A forum for Indian Pharmacy Professionals

Drug Regulatory Affairs - CMC Regulatory, Global regulatory, Medical Devices, Pharmaceutical Regulatory Details PPT and Guidelines and etc.
Forum rules: General rules are applicable for this forum- Find Here
  • User avatar
#2481
This guidance is intended to assist applicants preparing to submit to FDA abbreviated new drug applications (ANDAs). This guidance highlights common, recurring deficiencies that may lead to a delay in the approval of an ANDA. It also makes recommendations to applicants on how to avoid these deficiencies with the goal of minimizing the number of review cycles necessary for approval.

Guideline includes following details:
- PATENT AND EXCLUSIVITY DEFICIENCIES
- LABELING DEFICIENCIES
- PRODUCT QUALITY DEFICIENCIES
- BIOEQUIVALENCE DEFICIENCIES

To download the guidelines follow the below link.
Attachments:
(249.56 KiB) Downloaded 591 times
Similar Topics
Topics Statistics Last post
0 Replies 
1957 Views
by Admin
0 Replies 
665 Views
by Admin
0 Replies 
960 Views
by Admin
0 Replies 
1009 Views
by Admin
0 Replies 
845 Views
by Admin
long long title how many chars? lets see 123 ok more? yes 60

We have created lots of YouTube videos just so you can achieve [...]

Another post test yes yes yes or no, maybe ni? :-/

The best flat phpBB theme around. Period. Fine craftmanship and [...]

Do you need a super MOD? Well here it is. chew on this

All you need is right here. Content tag, SEO, listing, Pizza and spaghetti [...]

Lasagna on me this time ok? I got plenty of cash

this should be fantastic. but what about links,images, bbcodes etc etc? [...]

PharmD Info - Highlights